Research focus

The Cardiovascular Magnetic Resonance research group (CMR) is focused on development of new protocols of heart imaging and identifying novel imaging biomarkers for the prediction of early myocardial dysfunction. The main purpose is to improve the noninvasive diagnostics of early forms of myocardial diseases contributing especially to heart failure. Early and accurate diagnosis of myocardial dysfunction and structural abnormalities that are known to precede the development of manifest symptomatic heart failure can provide several potential benefits and can lead to better short-term and long-term prognosis of patients, decrease patient morbidity and mortality, improve their quality of life and potentially save public sources.

Research objectives

  • To test a novel CMR protocol to improve early detection of myocardial injury in Duchenne and Becker muscular dystrophy patients.
  • To prove that CMR can detect higher prevalence and earlier stages of cardiac involvement in patients with sarcoidosis in comparison with commonly used methods.
  • To find novel CMR and laboratory markers for the diagnosis of cardiotoxicity in oncological group of patients after cardiotoxic chemotherapy.

Technological equipment

MR 1,5T Philips Ingenia


Intellispace Discovery Portal 

Tomtec Arena

Top publications

  • MELUZÍN, J., JANOUŠEK, J., MAYER, J., GROCH, L., HORNACEK, I., HLINOMAZ, O., KALA, P., PANOVSKÝ, R., et al. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology. 2008; 128(2):185-192.
  • PANOVSKÝ, R., PLEVA, M., FEITOVÁ, V., et al. The Prognostic Impact of Myocardial Late Gadolinium Enhancement. Cardiology in Review. 2014, 22(3), 128-139.
  • PANOVSKÝ, R., PLEVA, M., FEITOVÁ, V., et al. Left atrium assessment: the evolving role of MRI. Journal of Cardiovascular Medicine. 2015, 16(10), 671-80.
  • PANOVSKÝ, R., BOROVA, J., PLEVA, M., et al. The unique value of cardiovascular magnetic resonance in patients with suspected acute coronary syndrome and culprit-free coronary angiograms. BMC Cardiovascular disorders. 2017, 17(1), 170.
  • PANOVSKÝ, R., PEŠL, M., HOLEČEK, T., et al. Cardiac profile of the Czech population of Duchenne muscular dystrophy patients: a cardiovascular magnetic resonance study with T1 mapping. Orphanet J Rare Dis 2019: 14:10.
  • PANOVSKÝ, R., DOUBKOVÁ, M., HOLEČEK, T., et al. Myocardial T1 mapping using SMART1Map and MOLLI mapping in asymptomatic patients with recent extracardiac sarcoidosis. NMR in Biomedicine. 2020;e4388.

Other selected results

  • Cardiovascular magnetic resonance provided a powerful incremental diagnostic value in the cohort of patients with suspected acute coronary syndrome and unobstructed coronary arteries. The CMR is highly recommended to be incorporated as an inalienable part of the diagnostic algorithms in these patients.

Team members

  • doc. MUDr. Roman Panovský, Ph.D.
  • MUDr. Věra Feitová
  • Anna Kubová
  • Bc. Pavlína Beierová
  • Mgr. Jitka Glossová
  • Ing. Tomáš Holeček
  • MUDr. Lucia Masárová
  • Dr. Mary Luz Mojica Pisciotti
  • MUDr. Lukáš Opatřil
  • Mgr. Jana Víšková
  • Bc. Kristýna Vítková

Principal Investigator

doc. MUDr. Roman Panovský, Ph.D.
doc. MUDr. Roman Panovský, Ph.D.
Principal Investigator Junior
Phone: +420 54 318 2409


Anna Kubová
Anna Kubová
Research Assistant
Phone: +420 54 318 5496